These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9692412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results.
    Steyn DW, Odendaal HJ.
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):155-9. PubMed ID: 9447368
    [Abstract] [Full Text] [Related]

  • 4. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
    Bolte AC, van Eyck J, Kanhai HH, Bruinse HW, van Geijn HP, Dekker GA.
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):371-7. PubMed ID: 9988803
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy.
    Moodley J, Gouws E.
    Br J Obstet Gynaecol; 1992 Sep; 99(9):727-30. PubMed ID: 1420010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
    Suonio S, Saarikoski S, Tahvanainen K, Pääkkönen A, Olkkonen H.
    Am J Obstet Gynecol; 1986 Jul; 155(1):122-5. PubMed ID: 3728580
    [Abstract] [Full Text] [Related]

  • 8. Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin.
    Steyn DW, Odendaal HJ.
    Obstet Gynecol Surv; 2000 Sep; 55(9):582-9. PubMed ID: 10975485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure.
    Reifart N, Kaltenbach M, Bussmann WD.
    Eur Heart J; 1984 Jul; 5(7):568-80. PubMed ID: 6479183
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
    Levenson J, Simon A, Achimastos A, Temmar M, Safar M.
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.
    Richter JA, Barankay A, Göb E, Späth P.
    J Cardiovasc Pharmacol; 1986 Jun; 8(1):109-15. PubMed ID: 2419672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
    van der Stroom JG, van Wezel HB, Langemeijer JJ, Korsten HH, Kooyman J, van der Starre PJ, Kal JE, Porsius M, van den Ende R, van Zwieten PA.
    J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):729-36. PubMed ID: 9327314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.